TanyaZarembaFischerMD

Neurology • West Haven, CT

Assistant Professor, Neurology, Yale University School of Medicine

Join to view full profile

Dr. Fischer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fischer's full profile

Already have an account?

Office
950 Campbell Ave
Building 34
West Haven, CT 06516
Phone+1 203-932-4724

Fax+1 203-937-3464

Education & Training

Yale-New Haven Medical CenterResidency, Neurology, 2003 - 2006
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 2002 - 2003
Rutgers Robert Wood Johnson Medical SchoolClass of 2002

Certifications & Licensure

CT State Medical License 2006 - 2025

Publications & Presentations

PubMed

27 citations
Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.
Sonja Krösser, Peter Wolna, Tanya Fischer, Ursula Boschert, Randall Stoltz
Journal of Clinical Pharmacology. 2015-09-01
64 citations
Neuropathic pain in diabetes—evidence for a central mechanism
Tanya Z. Fischer, Stephen G. Waxman
Nature Reviews. Neurology. 2010-08-01
96 citations
Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway.
Ashlee Van't Veer, Yangzhou Du, Tanya Z. Fischer, Deborah R. Boetig, Melissa R. Wood
Journal of Neuroscience Research. 2009-01-01

Press Mentions

Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s DiseaseFebruary 14th, 2017
Breast Cancer MetastaticDecember 9th, 2020